DNA cell cycle distribution and glutathione (GSH) content according to circadian stage in bone marrow of cancer patients
1992

Bone Marrow Cell Cycle and Glutathione Levels in Cancer Patients

Sample size: 15 publication 10 minutes Evidence: moderate

Author Information

Author(s): R. Smaaland, J.F. Abrahamsen, A.M. Svardal, K. Lote, P.M. Ueland

Primary Institution: University of Bergen

Hypothesis

The study investigates the circadian variations in DNA cell cycle distribution and glutathione content in the bone marrow of cancer patients.

Conclusion

The study found that bone marrow cells in cancer patients have a higher fraction in S-phase and G2/M-phase during the daytime compared to midnight, suggesting potential for optimizing cancer therapy.

Supporting Evidence

  • A significant correlation was found between S-phase and glutathione content (r = 0.42; P < 0.05).
  • Cells in S-phase showed a positive correlation with cells in G2/M-phase (r = 0.64; P < 0.0001).
  • A negative correlation was found between GSH content and age (r = 0.53; P < 0.005).
  • Cortisol levels were higher during daytime compared to midnight, indicating a normal cortisol pattern in most patients.

Takeaway

Doctors can find out when cancer patients' bone marrow is most active by checking it during the day and at night, which might help in giving better treatments.

Methodology

Bone marrow samples were taken from 15 cancer patients at daytime and midnight to measure DNA cell cycle distribution and glutathione content.

Limitations

The study did not measure GSH content specifically in mononucleated cells, which may affect the results.

Participant Demographics

Patients had a mean age of 48.7 years, with a range from 27 to 70 years.

Statistical Information

P-Value

P < 0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication